The Ultra-Processed Trap: Why a Healthy Diet Can’t Save Your Brain from Junk Food
Even if you strictly follow a nutrient-rich regimen like the Mediterranean diet, regularly consuming ultra-processed foods may completely undermine...
Search results for "U.S. market"
Celltrion Secures Historic FDA Interchangeability Status for Truxima
Celltrion announced on the 1st that the U.S. Food and Drug Administration has granted interchangeable status to Truxima (active ingredient:...
Samsung Biologics Labor Dispute Set for Limited Q2 Impact, but Second-Half Outlook Hinges on Union Deal and U.S. Plant Costs
With wage and collective bargaining talks between Samsung Biologics and its union still unresolved, analysts expect...
Rznomics Secures U.S. Patent for Alzheimer’s RNA Therapy Candidate RZ-003
Rznomics, a biopharmaceutical company specializing in RNA-based gene therapies, announced on the 24th that it has...
SCL Healthcare Secures U.S. Patent for Genetic Test Predicting Metabolic Syndrome Risk
SCL Healthcare has successfully secured a U.S. patent for a novel genetic testing technology designed to predict an...
New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment
Dementia medications do not yield uniform results for every patient; instead, their clinical efficacy depends heavily...
FDA Grants Streamlined Path for MediPost’s Cartistem, Slashing U.S. Trial Burden
The U.S. Food and Drug Administration has agreed to a significantly streamlined clinical path for Cartistem, a landmark...
South Korean Biotechs Race to Conquer the Untapped Global MASH Market
Fat accumulation in the liver can trigger severe inflammation even in individuals who completely abstain from alcohol.
The Fat-to-Brain Highway: How Aged Garlic Extract Remodels Muscle Health
"If you eat this and do not see sunlight for 100 days, you will become human." According to Korean mythology, those...
Hanmi Pharm Revives 'LAPSCOVERY' Momentum with $1.26B Eli Lilly Licensing Deal
Hanmi Pharmaceutical has licensed its novel drug candidate sonefpeglutide to global pharmaceutical giant Eli Lilly and...